Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.405
-0.005 (-0.35%)
Feb 12, 2026, 9:51 AM EST - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $460.68 million as of February 12, 2026. Its market cap has increased by 122.10% in one year.
Market Cap
460.68M
Enterprise Value
461.08M
1-Year Change
122.10%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $460.68M, an increase of 1,306.69%. That is a compound annual growth rate of 51.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 462.32M | 9.65% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 507.62M |
| Neumora Therapeutics | 499.62M |
| ADC Therapeutics | 488.70M |
| Verastem | 487.79M |
| Zevra Therapeutics | 487.54M |
| Prothena Corporation | 485.01M |
| 4D Molecular Therapeutics | 476.16M |
| Zura Bio | 475.61M |